These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24396453)

  • 21. Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation.
    Wang J; Li L; Wu L; Sun B; Du Y; Sun J; Wang Y; Fu Q; Zhang P; He Z
    Eur J Pharm Sci; 2017 Mar; 99():185-192. PubMed ID: 27989702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-time visualization of pH-responsive PLGA hollow particles containing a gas-generating agent targeted for acidic organelles for overcoming multi-drug resistance.
    Ke CJ; Chiang WL; Liao ZX; Chen HL; Lai PS; Sun JS; Sung HW
    Biomaterials; 2013 Jan; 34(1):1-10. PubMed ID: 23044041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment.
    Yuan X; Ji W; Chen S; Bao Y; Tan S; Lu S; Wu K; Chu Q
    Int J Nanomedicine; 2016; 11():2119-31. PubMed ID: 27307727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice.
    Kefayat A; Vaezifar S
    Int J Biol Macromol; 2019 Sep; 136():48-56. PubMed ID: 31195043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective breast cancer therapy based on palmitic acid-loaded PLGA nanoparticles.
    He Y; de Araújo Júnior RF; Cavalcante RS; Yu Z; Schomann T; Gu Z; Eich C; Cruz LJ
    Biomater Adv; 2023 Feb; 145():213270. PubMed ID: 36603405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells.
    Tahara K; Kato Y; Yamamoto H; Kreuter J; Kawashima Y
    J Microencapsul; 2011; 28(1):29-36. PubMed ID: 21171814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.
    Cao D; Zhang X; Akabar MD; Luo Y; Wu H; Ke X; Ci T
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):181-191. PubMed ID: 30686051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
    Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
    Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan-Dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage.
    Siddharth S; Nayak A; Nayak D; Bindhani BK; Kundu CN
    Sci Rep; 2017 May; 7(1):2143. PubMed ID: 28526868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
    van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
    Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
    Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential cardioprotective and anticancer effects of carvedilol either free or as loaded nanoparticles with or without doxorubicin in solid Ehrlich carcinoma-bearing mice.
    Zidan A; El Saadany AA; El Maghraby GM; Abdin AA; Hedya SE
    Toxicol Appl Pharmacol; 2023 Apr; 465():116448. PubMed ID: 36921847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of Anti-Cancer Activity of Benomyl Loaded Nanoparticles in Multidrug Resistant Cancer Cells.
    Kini S; Bahadur D; Panda D
    J Biomed Nanotechnol; 2015 May; 11(5):877-89. PubMed ID: 26349399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Charge-reversal-functionalized PLGA nanobubbles as theranostic agents for ultrasonic-imaging-guided combination therapy.
    Yang H; Shen X; Yan J; Xie X; Chen Z; Li T; Li S; Qin X; Wu C; Liu Y
    Biomater Sci; 2018 Aug; 6(9):2426-2439. PubMed ID: 30040100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
    Li JL; Zheng CL; Liu JP; Zhu JB
    Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.
    Pan ZZ; Wang HY; Zhang M; Lin TT; Zhang WY; Zhao PF; Tang YS; Xiong Y; Zeng YE; Huang YZ
    Acta Pharmacol Sin; 2016 Aug; 37(8):1110-20. PubMed ID: 27292613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of intracellular delivery of doxorubicin from poly(lactide-co-glycolide) nanoparticles by means of fluorescence lifetime imaging and confocal Raman microscopy.
    Romero G; Qiu Y; Murray RA; Moya SE
    Macromol Biosci; 2013 Feb; 13(2):234-41. PubMed ID: 23316003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.
    Lv L; Qiu K; Yu X; Chen C; Qin F; Shi Y; Ou J; Zhang T; Zhu H; Wu J; Liu C; Li G
    J Biomed Nanotechnol; 2016 May; 12(5):973-85. PubMed ID: 27305819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.